24/7 Patient Assistance: 760-405-8205

Richard Drake, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training

    dept_icon

    Indiana University

    Medical School

    dept_icon

    Western Michigan University Homer Stryker M.D.

    Internship

    dept_icon

    Ohio State University Hospital

    Residency

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    CLEVELAND CLINIC HOSPITAL

    Languages: English/Spanish

    (216) 445-0150

    9500 Euclid Ave Taussig Cancer Institute

    Cleveland, OH 44195

    Read More
  • Publications & Memberships

    Dr. Richard Drake has contributed to 3 publications.

    A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.

    Herzog, T. J.,Monk, B. J.,Rose, P. G.,Braly, P.,Hines, J. F.,Bell, M. C.,Wenham, R. M.,Secord, A. A.,Roman, L. D.,Einstein, M. H.,Drake, R. D.,Childs, B. H.; Gynecol. Oncol.. 2014 Jan 31.

    See more >>

    Mural nodules of clear cell carcinoma in a mucinous borderline tumor of the ovary: a case report

    Allende, D. S., Drake, R. D., Chen, L.; Patholog Res Int. 2010.

    See more >>

    A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...

    Miller, D.S., Blessing, J.A., Drake, R.D., Higgins, R., McMeekin, D.S., Puneky, L.V., Krasner, C.N.; Gynecol Oncol. 2009-12-01.

    See more >>